KRAS oncogene imparts its pro-tumoral activity via regulation of cell (proliferation, migration, invasion, apoptosis blockade, and metabolic adaptation) and non-cell autonomous (tumor microenvironment remodelling and immune suppression) mechanisms (Zhang et al., 2014). Here, KRAS is linked to neoplasm.